Silexion Therapeutics Corp - 8-K Filing

Silexion Therapeutics Corp completes 1-for-24 reverse share split and adjusts warrant terms accordingly (Items: 3.03 Material Modification to Rights of Security Holders, 5.03 below, on November 11, 2026, Silexion Therapeutics Corp (the “Company”) issued a notice (the “Warrant Adjustment Notice”) to holders of its p, 8.01 Other Events)

SEC EDGAR ·

Tickers: $SLXN

Read the full article at SEC EDGAR

More Regulatory news